Clinical Trial: ARC-21

Trial Status: Open
Disease Type: Esophageal/Gastric
Trial ID ARC-21
Sponsor ID Arcus Biosciences

A safety and efficacy study of domvanalimab + zimberelimab combination therapy with and without chemotherapy in adult participants with advanced upper gastrointestinal tract malignancies

Principal Investigator
Keeran R. Sampat, MD

Locations

Fairfax Office

Arlington Office

Gainesville Office

Learn More About This Trial
Other Relevant Trials
Trial ID AT148006
Sponsor ID ASPEN-06

A PHASE 2/3 STUDY OF ALX148 IN PATIENTS WITH ADVANCED HER2-OVEREXPRESSING GASTRIC/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA (ASPEN-06)

Principal Investigator
Samuel Lee, MD
Trial ID SGN-PDL1V
Sponsor ID SGNPDL1V-001

A Phase 1 Study of SGN-PDL1V in Advanced Solid Tumors